BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23044955)

  • 1. Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome.
    Han DP; Chin M; Simons KB; Albert DM
    Arch Ophthalmol; 2012 Oct; 130(10):1337-9. PubMed ID: 23044955
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes.
    Parolini B; Schumann RG; Cereda MG; Haritoglou C; Pertile G
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9074-83. PubMed ID: 22025575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular pathologic findings of neurofibromatosis type 2.
    McLaughlin ME; Pepin SM; Maccollin M; Choopong P; Lessell S
    Arch Ophthalmol; 2007 Mar; 125(3):389-94. PubMed ID: 17353411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green.
    La Heij EC; Dieudonné SC; Mooy CM; Diederen RM; Liem AT; van Suylen RJ; Hendrikse F
    Am J Ophthalmol; 2005 Dec; 140(6):1123-5. PubMed ID: 16376661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rationale for membrane peeling in the repair of stage 4 macular holes.
    Ang A; Snead DR; James S; Yeo YC; Satchi K; Morris AH; Poulson AV; Scott JD; Snead MP
    Eye (Lond); 2006 Feb; 20(2):208-14. PubMed ID: 15803171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcome and pathological findings in macular epiretinal membrane caused by neurofibromatosis type 2.
    Kunikata H; Nishiguchi KM; Watanabe M; Nakazawa T
    Digit J Ophthalmol; 2022; 28(1):12-16. PubMed ID: 35573141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrence of an idiopathic vasocentric epiretinal membrane: clinical and surgical particularities].
    Sandali O; Basli E; Borderie V; Laroche L; Monin C
    J Fr Ophtalmol; 2012 Jan; 35(1):48.e1-5. PubMed ID: 21719147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular rake for removal of epiretinal membranes.
    Johnson TM; Glaser BM
    Am J Ophthalmol; 2006 Feb; 141(2):381-3. PubMed ID: 16458701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does vitrectomy affect diabetic macular edema?
    Stefánsson E; Landers MB
    Am J Ophthalmol; 2006 May; 141(5):984; author reply 984-5. PubMed ID: 16678538
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of glial fibrillary acidic protein accumulation after retinal tack insertion for intraocular fixation of epiretinal implants.
    Ivastinovic D; Langmann G; Asslaber M; Georgi T; Wedrich A; Velikay-Parel M
    Acta Ophthalmol; 2012 Aug; 90(5):e416-7. PubMed ID: 22151693
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane.
    Kim J; Rhee KM; Woo SJ; Yu YS; Chung H; Park KH
    Am J Ophthalmol; 2010 Nov; 150(5):701-709.e1. PubMed ID: 20719296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.
    Suh MH; Seo JM; Park KH; Yu HG
    Am J Ophthalmol; 2009 Mar; 147(3):473-480.e3. PubMed ID: 19054492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium.
    Cohn AD; Quiram PA; Drenser KA; Trese MT; Capone A
    Retina; 2009 Jun; 29(6):825-30. PubMed ID: 19276871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the time course of macular pigment density measurement in patients with a macular hole--clinical course and impact of surgery].
    Jordan F; Jentsch S; Augsten R; Strobel J; Dawczynski J
    Klin Monbl Augenheilkd; 2012 Nov; 229(11):1124-9. PubMed ID: 22961042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical removal of the internal limiting membrane in diabetic cystoid macular edema.
    Gandorfer A; Kampik A
    Retina; 2006 Apr; 26(4):485-6; author reply 486-7. PubMed ID: 16603977
    [No Abstract]   [Full Text] [Related]  

  • 16. Epiretinal membranes indicate a severe phenotype of neurofibromatosis type 2.
    Sisk RA; Berrocal AM; Schefler AC; Dubovy SR; Bauer MS
    Retina; 2010 Apr; 30(4 Suppl):S51-8. PubMed ID: 20386093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pars plana vitrectomy with and without peeling of the inner limiting membrane (ILM) for diabetic macular edema.
    Gandorfer A; Kampik A
    Retina; 2008 Jan; 28(1):187-8; author reply 188-9. PubMed ID: 18185166
    [No Abstract]   [Full Text] [Related]  

  • 18. Idiopathic epiretinal membranes: cell type, growth factor expression, and fluorescein angiographic and retinal photographic correlations.
    Mandelcorn E; Khan Y; Javorska L; Cohen J; Howarth D; Mandelcorn M
    Can J Ophthalmol; 2003 Oct; 38(6):457-63. PubMed ID: 14620032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic differences in epiretinal membranes on ocular coherence tomography as a predictive factor for surgical outcome.
    Kinoshita T; Kovacs KD; Wagley S; Arroyo JG
    Retina; 2011 Sep; 31(8):1692-8. PubMed ID: 21642900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.
    Zhao F; Gandorfer A; Haritoglou C; Scheler R; Schaumberger MM; Kampik A; Schumann RG
    Retina; 2013 Jan; 33(1):77-88. PubMed ID: 22914684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.